Antigen–Antibody Complexes

Abbas AK, Lichtman AH, Pillai S (2014) Basic immunology: functions and disorders of the immune system. Elsevier Health Sciences

Abbott WM, Damschroder MM, Lowe DC (2014) Current approaches to fine mapping of antigen–antibody interactions. Immunology 142(4):526–535

Adachi M, Kurihara Y, Nojima H, Takeda-Shitaka M, Kamiya K, Umeyama H (2003) Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL–hyHEL-10 complex. Protein Sci 12(10):2125–2131

Ahmad TA, Eweida AE, Sheweita SA (2016) B-cell epitope mapping for the design of vaccines and effective diagnostics. Trials Vaccinol 5:71–83

Al-Lazikani B, Lesk AM, Chothia C (1997) Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 273(4):927–948

Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21–50

Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235–242

Berzofsky JA, Schechter AN (1981) The concepts of crossreactivity and specificity in immunology. Mol Immunol 18(8):751–763

Bhat TN, Bentley GA, Boulot G, Greene MI, Tello D, Dall’Acqua W, Souchon H, Schwarz FP, Mariuzza RA, Poljak RJ (1994) Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci USA 91(3):1089–1093

Birtalan S, Zhang Y, Fellouse FA, Shao L, Schaefer G, Sidhu SS (2008) The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol 377(5):1518–1528

Boekema EJ, Folea M, Kouřil R (2009) Single particle electron microscopy. Photosynth Res 102(2–3):189

Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18):1141–1149

Bogan AA, Thorn KS (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280(1):1–9

Borghesi L, Milcarek C (2006) From B cell to plasma cell. Immunol Res 36(1–3):27–32

Bostrom J, Yu S-F, Kan D, Appleton BA, Lee CV, Billeci K, Man W, Peale F, Ross S, Wiesmann C (2009) Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 323(5921):1610–1614

Bouvet J-P, Marone G (2007) Protein Fv: an endogenous immunoglobulin superantigen and superallergen. Chem Immunol Allergy 93:58–76. Karger Publishers

Bouvet JP, Pires R, Lunel-Fabiani F, Crescenzo-Chaigne B, Maillard P, Valla D, Opolon P, Pillot J (1990) Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol 145(4):1176–1180

Braden BC, Fields BA, Poljak RJ (1995) Conservation of water molecules in an antibody–antigen interaction. J Mol Recognit 8(5):317–325

Burton OT, Oettgen HC (2011) Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev 242(1):128–143

Capra JD, Kehoe JM (1974) Variable region sequences of five human immunoglobulin heavy chains of the VHIII subgroup: definitive identification of four heavy chain hypervariable regions. Proc Natl Acad Sci USA 71(3):845–848

Casadevall A, Janda A (2012) Immunoglobulin isotype influences affinity and specificity. Proc Natl Acad Sci USA 109(31):12272–12273

Cauerhff A, Goldbaum FA, Braden BC (2004) Structural mechanism for affinity maturation of an anti-lysozyme antibody. Proc Natl Acad Sci 101(10):3539–3544

Cavacini LA, Kuhrt D, Duval M, Mayer K, Posner MR (2003) Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals. AIDS Res Hum Retroviruses 19(9):785–792

Chen JZ, Settembre EC, Aoki ST, Zhang X, Bellamy AR, Dormitzer PR, Harrison SC, Grigorieff N (2009a) Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc Natl Acad Sci USA 106(26):10644–10648

Chen K, Xu W, Wilson M, He B, Miller NW, Bengten E, Edholm E-S, Santini PA, Rath P, Chiu A (2009b) Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell–stimulating programs in basophils. Nat Immunol 10(8):889

Chong LT, Duan Y, Wang L, Massova I, Kollman PA (1999) Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7. Proc Natl Acad Sci USA 96(25):14330–14335

Chothia C, Lesk AM (1987) Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 196(4):901–917

Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR (1989) Conformations of immunoglobulin hypervariable regions. Nature 342(6252):877

Chruszcz M, Wlodawer A, Minor W (2008) Determination of protein structures—a series of fortunate events. Biophys J 95(1):1–9

Chruszcz M, Pomes A, Glesner J, Vailes LD, Osinski T, Porebski PJ, Majorek KA, Heymann PW, Platts-Mills TA, Minor W, Chapman MD (2012) Molecular determinants for antibody binding on group 1 house dust mite allergens. J Biol Chem 287(10):7388–7398

Dalkas GA, Teheux F, Kwasigroch JM, Rooman M (2014) Cation–π, amino–π, π–π, and H‐bond interactions stabilize antigen–antibody interfaces. Proteins: Struct Funct Bioinform 82(9):1734–1746

Davies DR, Sheriff S, Padlan EA (1988) Antibody-antigen complexes. J Biol Chem 263(22):10541–10544

De Genst E, Silence K, Ghahroudi MA, Decanniere K, Loris R, Kinne J, Wyns L, Muyldermans S (2005) Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires. J Biol Chem 280(14):14114–14121

De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J, Muyldermans S, Wyns L (2006) Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci USA 103(12):4586–4591

DeKosky BJ, Lungu OI, Park D, Johnson EL, Charab W, Chrysostomou C, Kuroda D, Ellington AD, Ippolito GC, Gray JJ, Georgiou G (2016) Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. Proc Natl Acad Sci 113(19):E2636–2645

Dingjan T, Spendlove I, Durrant LG, Scott AM, Yuriev E, Ramsland PA (2015) Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies. Mol Immunol 67(2):75–88

Donnarumma D, Bottomley MJ, Malito E, Settembre E, Ferlenghi I, Cozzi R (2015) Structural biology in vaccine research. In: Advanced vaccine research methods for the decade of vaccines, p 103

Durandy A (2003) Mini-review Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation. Eur J Immunol 33(8):2069–2073

Elek S, Smith BK, Highman W (1964) The interaction of antigen and antibody in agglutination: a study by electron microscopy. Immunology 7(5):570

Fanning SW, Horn JR (2011) An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop. Protein Sci 20(7):1196–1207

Fraser JD (2011) Clarifying the mechanism of superantigen toxicity. PLoS Biol 9(9):e1001145

Freeman CL, Sehn L (2018) Anti-CD20 directed therapy of B cell lymphomas: are new agents really better? Curr Oncol Rep 20(12):103

Gala FA, Morrison SL (2002) The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. J Biol Chem 277(32):29005–29011

Geisberger R, Lamers M, Achatz G (2006) The riddle of the dual expression of IgM and IgD. Immunology 118(4):429–437

Glesner J, Vailes LD, Schlachter C, Mank N, Minor W, Osinski T, Chruszcz M, Chapman MD, Pomes A (2017) Antigenic determinants of Der p 1: specificity and cross-reactivity associated with IgE antibody recognition. J Immunol 198(3):1334–1344

Glesner J, Kapingidza AB, Godzwon M, Offermann LR, Mueller GA, DeRose EF, Wright P, Richardson CM, Woodfolk JA, Vailes LD, Wünschmann S, London RE, Chapman MD, Ohlin M, Chruszcz M, Pomés A (2019) Human IgE antibody binding site on Der p 2 for the design of a recombinant allergen for immunotherapy. J Immunol 203(9):2545–2556

Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet J-P, Capron M (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367(6459):183

Greenberg AS, Avila D, Hughes M, Hughes A, Mckinney EC, Flajnik MF (1995) A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374(6518):168–173

Grönwall C, Vas J, Silverman GJ (2012) Protective roles of natural IgM antibodies. Front Immunol 3:66

Gruber K, Zhou B, Houk KN, Lerner RA, Shevlin CG, Wilson IA (1999) Structural basis for antibody catalysis of a disfavored ring closure reaction. Biochemistry 38(22):7062–7074

Haidar JN, Yuan QA, Zeng L, Snavely M, Luna X, Zhang H, Zhu W, Ludwig DL, Zhu Z (2012) A universal combinatorial design of antibody framework to graft distinct cdr sequences: a bioinformatics approach. Proteins: Struct Funct Bioinform 80(3):896–912

Haji-Ghassemi O, Blackler RJ, Martin Young N, Evans SV (2015) Antibody recognition of carbohydrate epitopes. Glycobiology 25(9):920–952

Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363(6428):446–448

Harmsen MM, Ruuls RC, Nijman IJ, Niewold TA, Frenken LGJ, de Geus B (2000) Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immunol 37(10):579–590

Harris LJ, Larson SB, Hasel KW, McPherson A (1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36(7):1581–1597

Harris LJ, Skaletsky E, McPherson A (1998) Crystallographic structure of an intact IgG1 monoclonal antibody. J Mol Biol 275(5):861–872

Henry KA, MacKenzie CR (2018) Antigen recognition by single-domain antibodies: structural latitudes and constraints. MAbs 10(6):815–826

Hewat EA, Verdaguer N, Fita I, Blakemore W, Brookes S, King A, Newman J, Domingo E, Mateu MG, Stuart DI (1997) Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. EMBO J 16(7):1492–1500

Huber R (1980) Spatial structure of immunoglobulin molecules. Klin Wochenschr 58(22):1217–1231

Jahnichen S, Blanchetot C, Maussang D, Gonzalez-Pajuelo M, Chow KY, Bosch L, De Vrieze S, Serruys B, Ulrichts H, Vandevelde W, Saunders M, De Haard HJ, Schols D, Leurs R, Vanlandschoot P, Verrips T, Smit MJ (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc Natl Acad Sci 107(47):20565–20570

Janeway CA Jr, Travers P, Walport M, Shlomchik MJ (2001) The structure of a typical antibody molecule. In: Immunobiology: the immune system in health and disease, 5th edn. Garland Science

Jeffrey PD, Bajorath J, Chang CY, Yelton D, Hellström I, Hellström KE, Sheriff S (1995) The X-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol 2(6):466

Jolles S, Sewell WA, Misbah SA (2005) Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 142(1):1–11

Karp CL (2010) Guilt by intimate association: what makes an allergen an allergen? J Allergy Clin Immunol 125(5):955–960

Keskin O (2007) Binding induced conformational changes of proteins correlate with their intrinsic fluctuations: a case study of antibodies. BMC Struct Biol 7(1):31

Kettleborough CA, Saldanha J, Heath VJ, Morrison CJ, Bendig MM (1991) Humanization of a mouse monoclonal antibody by CDR–grafting: the importance of framework residues on loop conformation. Protein Eng Des Sel 4(7):773–783

Khan T, Salunke DM (2014) Adjustable locks and flexible keys: plasticity of epitope–paratope interactions in germline antibodies. J Immunol 192(11):5398–5405

Kholodenko RV, Kalinovsky DV, Doronin II, Ponomarev ED, Kholodenko IV (2019) Antibody fragments as potential biopharmaceuticals for cancer therapy: success and limitations. Curr Med Chem 26(3):396–426

King MT, Brooks CL (2018) Epitope mapping of antibody-antigen interactions with x-ray crystallography. In: Epitope Mapping Protocols. Springer, Switzerland, pp 13–27

Kringelum JV, Nielsen M, Padkjær SB, Lund O (2013) Structural analysis of B-cell epitopes in antibody: protein complexes. Mol Immunol 53(1–2):24–34

Kunik V, Ofran Y (2013) The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops. Protein Eng Des Sel 26(10):599–609

LeBrasseur N (2003) A view of antibody maturation. J Cell Biol 161(5):834

Leder P (1982) The genetics of antibody diversity. Sci Am 246(5):102–115

Lescar J, Pellegrini M, Souchon H, Tello D, Poljak RJ, Peterson N, Greene M, Alzari PM (1995) Crystal-structure of a cross-reaction complex between Fab F9.13.7 and guinea-fowl lysozyme. J Biol Chem 270(30):18067–18076.

Li Y, Lipschultz CA, Mohan S, Smith-Gill SJ (2001) Mutations of an epitope hot-spot residue alter rate limiting steps of antigen−antibody protein−protein associations. Biochemistry 40(7):2011–2022

Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA (2003) X-ray snapshots of the maturation of an antibody response to a protein antigen. Nat Struct Biol 10(6):482–488

Liang Y, Guttman M, Davenport TM, Hu S-L, Lee KK (2016) Probing the impact of local structural dynamics of conformational epitopes on antibody recognition. Biochemistry 55(15):2197–2213

Liao HX, Alam SM, Mascola JR, Robinson J, Ma BJ, Montefiori DC, Rhein M, Sutherland LL, Scearce R, Haynes BF (2004) Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins. J Virol 78(10):5270–5278

Ludwig DL, Pereira DS, Zhu Z, Hicklin DJ, Bohlen P (2003) Monoclonal antibody therapeutics and apoptosis. Oncogene 22(56):9097–9106

MacCallum RM, Martin AC, Thornton JM (1996) Antibody-antigen interactions: contact analysis and binding site topography. J Mol Biol 262(5):732–745

MacRaild CA, Richards JS, Anders RF, Norton RS (2016) Antibody recognition of disordered antigens. Structure 24(1):148–157

Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein. Nat Med 1(3):237

Mari A, Iacovacci P, Afferni C, Barletta B, Tinghino R, Di Felice G, Pini C (1999) Specific IgE to cross-reactive carbohydrate determinants strongly affect the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol 103(6):1005–1011

Mariuzza RA, PoIjak RJ (1993) The basics of binding: mechanisms of antigen recognition and mimicry by antibodies. Curr Opin Immunol 5(1):50–55

Market E, Papavasiliou FN (2003) V(D)J recombination and the evolution of the adaptive immune system. PLoS Biol 1(1):e16

Marone G (2007) Superantigens and superallergens, vol 93. Karger Medical and Scientific Publishers, Basel

Marone G, Spadaro G, Liccardo B, Rossi FW, D’Orio C, Detoraki A (2006) Superallergens: a new mechanism of immunologic activation of human basophils and mast cells. Inflamm Res 55(Suppl 1):S25–27

Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB (2015) Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J Autoimmun 57:1–13

Meulenbroek LA, de Jong RJ, den Hartog Jager CF, Monsuur HN, Wouters D, Nauta AJ, Knippels LM, van Neerven RJ, Ruiter B, Leusen JH (2013) IgG antibodies in food allergy influence allergen–antibody complex formation and binding to B cells: a role for complement receptors. J Immunol 191(7):3526–3533

Mimura Y, Church S, Ghirlando R, Ashton P, Dong S, Goodall M, Lund J, Jefferis R (2000) The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol 37(12–13):697–706

Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, Goodall M, Jefferis R (2001) Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding. J Biol Chem 276(49):45539–45547

Mitchell LS, Colwell LJ (2018) Analysis of nanobody paratopes reveals greater diversity than classical antibodies. Protein Eng Des Sel 31(7–8):267–275

Mitropoulou AN, Bowen H, Dodev TS, Davies AM, Bax HJ, Beavil RL, Beavil AJ, Gould HJ, James LK, Sutton BJ (2018) Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition. Proc Natl Acad Sci 115(37):E8707–E8716

Moalli F, Doni A, Deban L, Zelante T, Zagarella S, Bottazzi B, Romani L, Mantovani A, Garlanda C (2010) Role of complement and Fcγ receptors in the protective activity of the long pentraxin PTX3 against aspergillus fumigatus. Blood 116(24):5170–5180

Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R (1994) Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng 7(9):1129–1135

Narayanan A, Sellers BD, Jacobson MP (2009) Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains. J Mol Biol 388(5):941–953

Nelson AL Antibody fragments: hope and hype. In: MAbs, 2010. vol 1. Taylor & Francis, pp 77–83

Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310(5753):1510–1512

North B, Lehmann A, Dunbrack RL Jr (2011) A new clustering of antibody CDR loop conformations. J Mol Biol 406(2):228–256

Oettgen HC, Geha RS (1999) IgE in asthma and atopy: cellular and molecular connections. J Clin Invest 104(7):829–835

Padlan EA (1994) Anatomy of the antibody molecule. Mol Immunol 31(3):169–217

Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR (1989) Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci 86(15):5938–5942

Padlan EA, Abergel C, Tipper J (1995) Identification of specificity-determining residues in antibodies. FASEB J. 9(1):133–139

Pan R, Chen Y, Vaine M, Hu G, Wang S, Lu S, Kong XP (2015) Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding. Emerg Microbes Infect 4(7):e44

Parker DC (1993) T cell-dependent B cell activation. Annu Rev Immunol 11(1):331–360

Peng H-P, Lee KH, Jian J-W, Yang A-S (2014) Origins of specificity and affinity in antibody–protein interactions. Proc Natl Acad Sci USA 111(26):E2656–E2665

Platts-Mills TA (2001) The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 164 (supplement_1):S1-S5

Pollara J, Tay MZ (2019) Antibody-dependent cellular phagocytosis in antiviral immune responses. Front Immunol 10:332

Pons J, Stratton JR, Kirsch JF (2002) How do two unrelated antibodies, HyHEL‐10 and F9. 13.7, recognize the same epitope of hen egg‐white lysozyme? Protein Sci 11(10):2308–2315

Potocnakova L, Bhide M, Pulzova LB (2016) An introduction to B-cell epitope mapping and in silico epitope prediction. J Immunol Res 2016:6760830

Presta L, Shields R, O’Connell L, Lahr S, Porter J, Gorman C, Jardieu P (1994) The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 269(42):26368–26373

Rafiq K, Bergtold A, Clynes R (2002) Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest 110(1):71–79

Raghunathan G, Smart J, Williams J, Almagro JC (2012) Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. J Mol Recognit 25(3):103–113

Robin G, Sato Y, Desplancq D, Rochel N, Weiss E, Martineau P (2014) Restricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody–antigen complexes. J Mol Biol 426(22):3729–3743

Rosen O, Anglister J (2009) Epitope mapping of antibody–antigen complexes by nuclear magnetic resonance spectroscopy. In: Epitope mapping protocols. Springer, Switzerland, pp 37–57

Rouet R, Dudgeon K, Christie M, Langley D, Christ D (2015) Fully human VH single domains that rival the stability and cleft recognition of camelid antibodies. J Biol Chem 290(19):11905–11917

Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA (2001) Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293(5532):1155–1159

Schroeder HW Jr, Cavacini L (2010) Structure and function of immunoglobulins. J Allergy Clin Immunol 125(2):S41–S52

Sela-Culang I, Kunik V, Ofran Y (2013) The structural basis of antibody-antigen recognition. Front Immunol 4:302

Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel BC, Davies DR (1987) Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA 84(22):8075–8079

Simonelli L, Pedotti M, Bardelli M, Jurt S, Zerbe O, Varani L (2018) Mapping antibody epitopes by solution NMR spectroscopy: practical considerations. In: Epitope mapping protocols. Springer, Switzerland, pp 29–51

Sinha N, Smith-Gill SJ (2002) Electrostatics in protein binding and function. Curr Protein Pept Sci 3(6):601–614

Sinha N, Mohan S, Lipschultz CA, Smith-Gill SJ (2002) Differences in electrostatic properties at antibody-antigen binding sites: Implications for specificity and cross-reactivity. Biophys J 83(6):2946–2968

Skiniotis G, Southworth DR (2016) Single-particle cryo-electron microscopy of macromolecular complexes. Microscopy 65(1):9–22

Spiegelberg HL (1989) Biological role of different antibody classes. Int Arch Allergy Immunol 90(Suppl. 1):22–27

Spuergin P, Mueller H, Walter M, Schiltz E, Forster J (1996) Allergenic epitopes of bovine αs1-casein recognized by human IgE and IiG. Allergy 51(5):306–312

Stanfield RL, Dooley H, Flajnik MF, Wilson IA (2004) Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science 305(5691):1770–1773

Stanfield RL, Gorny MK, Zolla-Pazner S, Wilson IA (2006a) Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J Virol 80(12):6093–6105

Stanfield RL, Zemla A, Wilson IA, Rupp B (2006b) Antibody elbow angles are influenced by their light chain class. J Mol Biol 357(5):1566–1574

Stanfield RL, De Castro C, Marzaioli AM, Wilson IA, Pantophlet R (2015) Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose. Glycobiology 25(4):412–419

Stavnezer J, Amemiya CT (2004) Evolution of isotype switching. In: Seminars in immunology, vol 4. Elsevier, Amsterdam, pp 257–275

Strohl W, Strohl L (2013) Antibody fragments as therapeutics. Therap Anti Eng: Curr Fut Adv Driv Strong Growth Area Pharm Ind 265–299

Theofilopoulos AN, Dixon FJ (1980) Immune complexes in human diseases: a review. Am J Pathol 100(2):529–594

Tian X, Vestergaard B, Thorolfsson M, Yang Z, Rasmussen HB, Langkilde AE (2015) In-depth analysis of subclass-specific conformational preferences of IgG antibodies. IUCrJ 2(1):9–18

Torres M, Casadevall A (2008) The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol 29(2):91–97

Townsend CL, Laffy JM, Wu Y-CB, Silva O’Hare J, Martin V, Kipling D, Fraternali F, Dunn-Walters DK (2016) Significant differences in physicochemical properties of human immunoglobulin kappa and lambda CDR3 regions. Front Immunol 7:388

Tudor D, Yu H, Maupetit J, Drillet A-S, Bouceba T, Schwartz-Cornil I, Lopalco L, Tuffery P, Bomsel M (2012) Isotype modulates epitope specificity, affinity, and antiviral activities of anti–HIV-1 human broadly neutralizing 2F5 antibody. Proc Natl Acad Sci USA 109(31):12680–12685

Underdown BJ, Schiff JM (1986) Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 4(1):389–417

Van Kaer L (2018) How superantigens bind MHC. J Immunol 201(7):1817–1818

Van Regenmortel MH (2009) What is a B-cell epitope? In: Epitope mapping protocols. Springer, Switzerland, pp 3–20

Van Regenmortel MH (2014) Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition. J Mol Recognit 27(11):627–639

Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520

Visciano ML, Tuen M, Gorny MK, Hioe CE (2008) In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120. Virology 372(2):409–420

Webster DM, Henry AH, Rees AR (1994) Antibody-antigen interactions. Curr Opin Struct Biol 4(1):123–129

Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC (1997) Structural insights into the evolution of an antibody combining site. Science 276(5319):1665–1669

Wei H, Mo J, Tao L, Russell RJ, Tymiak AA, Chen G, Iacob RE, Engen JR (2014) Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discov Today 19(1):95–102

Weitzner BD, Dunbrack RL Jr, Gray JJ (2015) The origin of CDR H3 structural diversity. Structure 23(2):302–311

Wen YM, Mu L, Shi Y (2016) Immunoregulatory functions of immune complexes in vaccine and therapy. EMBO Mol Med 8(10):1120–1133

Wider G, Wüthrich K (1999) NMR spectroscopy of large molecules and multimolecular assemblies in solution. Curr Opin Struct Biol 9(5):594–601

Williams CM, Galli SJ (2000) The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105(5):847–859

Wilson IA, Stanfield RL (1994) Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 4(6):857–867

Wlodawer A, Minor W, Dauter Z, Jaskolski M (2008) Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 275(1):1–21

Wood P (2012) Human normal immunoglobulin in the treatment of primary immunodeficiency diseases. Ther Clin Risk Manag 8:157–167

Wu S, Avila-Sakar A, Kim J, Booth DS, Greenberg CH, Rossi A, Liao M, Li X, Alian A, Griner SL (2012) Fabs enable single particle cryoEM studies of small proteins. Structure 20(4):582–592

Xia Y, Pawar RD, Nakouzi AS, Herlitz L, Broder A, Liu K, Goilav B, Fan M, Wang L, Li Q-Z (2012) The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. J Autoimmun 39(4):398–411

Xiang J, Sha Y, Jia Z, Prasad L, Delbaere LT (1995) Framework residues 71 and 93 of the chimeric B72. 3 antibody are major determinants of the conformation of heavy-chain hypervariable loops. Elsevier

Xiang J, Prasad L, Delbaere LT, Jia Z (1999) Light-chain framework region residue Tyr71 of chimeric B72. 3 antibody plays an important role in influencing the TAG72 antigen binding. Protein Eng 12(5):417–421

Zhao L, Li J (2010) Mining for the antibody-antigen interacting associations that predict the B cell epitopes. BMC Struct Biol 10(1):S6

Zhu XY, Dickerson TJ, Rogers CJ, Kaufmann GF, Mee JM, McKenzie KM, Janda KD, Wilson IA (2006) Complete reaction cycle of a cocaine catalytic antibody at atomic resolution. Structure 14(2):205–216

Zuiderweg ER (2002) Mapping protein−protein interactions in solution by NMR spectroscopy. Biochemistry 41(1):1–7